Ken Fisher Ironwood Pharmaceuticals Inc Transaction History

Fisher Asset Management, LLC

$243 Billion
Q3 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	BUY	$8.32 - $15.45 $15,109 - $28,057	1,816 Added 1.76%	104,947 $914,000
Q4 2023 Mar 05, 2024	BUY	$8.79 - $11.51 $1,757 - $2,302	200 Added 0.19%	103,131 $1.18 Million
Q3 2023 Nov 13, 2023	BUY	$8.25 - $11.35 $217,197 - $298,811	26,327 Added 34.37%	102,931 $991,000
Q2 2023 Dec 12, 2023	SELL	$10.1 - $11.6 $265,902 - $305,393	-26,327 Reduced 25.58%	76,604 $815,000
Q2 2023 Aug 08, 2023	BUY	$10.1 - $11.6 $1,878 - $2,157	186 Added 0.24%	76,604 $815,000
Q1 2023 Dec 12, 2023	SELL	$10.37 - $12.56 $274,939 - $333,003	-26,513 Reduced 25.76%	76,418 $803,000
Q1 2023 May 01, 2023	BUY	$10.37 - $12.56 $12,143 - $14,707	1,171 Added 1.56%	76,418 $804,000
Q4 2022 Feb 03, 2023	SELL	$9.9 - $12.43 $212,790 - $267,170	-21,494 Reduced 22.22%	75,247 $932,000
Q3 2022 Nov 08, 2022	SELL	$10.14 - $12.38 $487,176 - $594,797	-48,045 Reduced 33.18%	96,741 $1 Million
Q2 2022 Aug 09, 2022	BUY	$11.05 - $12.72 $2,972 - $3,421	269 Added 0.19%	144,786 $1.67 Million
Q4 2021 Feb 02, 2022	BUY	$10.86 - $13.95 $636,385 - $817,456	58,599 Added 68.2%	144,517 $1.69 Million
Q3 2021 Oct 26, 2021	SELL	$11.92 - $13.92 $199,135 - $232,547	-16,706 Reduced 16.28%	85,918 $1.12 Million
Q2 2021 Jul 27, 2021	BUY	$10.16 - $13.11 $214,436 - $276,699	21,106 Added 25.89%	102,624 $1.32 Million
Q1 2021 Apr 27, 2021	BUY	$9.04 - $11.86 $12,014 - $15,761	1,329 Added 1.66%	81,518 $911,000
Q4 2020 Jan 29, 2021	BUY	$9.05 - $12.2 $150,745 - $203,215	16,657 Added 26.22%	80,189 $913,000
Q3 2020 Nov 10, 2020	SELL	$8.99 - $10.74 $224,651 - $268,381	-24,989 Reduced 28.23%	63,532 $571,000
Q2 2020 Aug 07, 2020	BUY	$9.14 - $11.97 $484 - $634	53 Added 0.06%	88,521 $914,000
Q1 2020 Apr 28, 2020	SELL	$8.58 - $14.01 $135,666 - $221,526	-15,812 Reduced 15.16%	88,468 $893,000
Q4 2019 Feb 12, 2020	SELL	$8.22 - $14.0 $930,972 - $1.59 Million	-113,257 Reduced 52.06%	104,280 $1.39 Million
Q2 2019 Jul 30, 2019	BUY	$9.8 - $12.89 $304,868 - $400,995	31,109 Added 16.69%	217,537 $2.38 Million
Q1 2019 Apr 22, 2019	SELL	$8.27 - $12.73 $30,756 - $47,342	-3,719 Reduced 1.96%	186,428 $2.52 Million
Q4 2018 Jan 25, 2019	SELL	$7.8 - $16.13 $85,971 - $177,784	-11,022 Reduced 5.48%	190,147 $1.97 Million
Q3 2018 Oct 24, 2018	SELL	$14.31 - $17.65 $144,116 - $177,753	-10,071 Reduced 4.77%	201,169 $3.71 Million
Q2 2018 Jul 09, 2018	SELL	$11.83 - $16.2 $667,945 - $914,684	-56,462 Reduced 21.09%	211,240 $4.04 Million
Q1 2018 May 11, 2018	SELL	$11.13 - $13.63 $3.47 Million - $4.25 Million	-312,166 Reduced 53.83%	267,702 $4.13 Million
Q1 2018 Apr 19, 2018	BUY	$11.13 - $13.63 $3.23 Million - $3.96 Million	290,654 Added 100.5%	579,868 $8.95 Million
Q4 2017 Jan 24, 2018	BUY	$12.16 - $14.58 $1.07 Million - $1.29 Million	88,155 Added 43.85%	289,214 $4.34 Million
Q3 2017 Oct 17, 2017	BUY	$12.07 - $14.87 $2.43 Million - $2.99 Million	201,059	201,059 $3.17 Million

Others Institutions Holding IRWD

# of Institutions

238

Shares Held

162M

Call Options Held

11.2M

Put Options Held

9.1K

Black Rock Inc. New York, NY

22.9M
Shares

$80.8 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

22M
Shares

$77.8 Million
0.0% of portfolio
Sarissa Capital Management LP Greenwich, CT

16.4M
Shares

$57.9 Million
16.75% of portfolio
Pacer Advisors, Inc. Malvern, PA

11.3M
Shares

$39.8 Million
0.11% of portfolio
State Street Corp Boston, MA

9.92M
Shares

$35 Million
0.0% of portfolio

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $541M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track Ken Fisher's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.

Account